AUSTIN, Texas, Nov. 01, 2016 -- SmallCapVoice.com, Inc. (SCV) and Michael James Enterprises, Inc. (OTCQB:MJTV) today announced that the Company’s Brand Ambassador, Dr. Kristina Kincaid, is featured in an audio interview at SmallCapVoice.com. The interview outlining the company’s business strategy and future regarding its new neuroceutical female sexual arousal booster, Voluptas, and the sexuality project series of classes and workshops is now available and can be heard at http://smallcapvoice.com/blog/10-31-16-smallcapvoice-interview-with-michael-james-enterprises-inc-mjtv.
Brand Ambassador, Dr. Kristina Kincaid, called in to SmallCapVoice.com to discuss the company’s revolutionary new product, the state of sexual health in the world today, and much more in this exciting new interview.
In the interview Kincaid commented, “These are exciting times for women. We can now embrace ourselves as our own sexual beings and delve into what completes us as women. I am thrilled to be a part of the team behind the Voluptas, The Sexuality Project classes, conferences and workshops. It was a pleasure discussing our achievements and progress so far with SmallCapVoice.com.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason.
Michael James Enterprises, Inc. 760 Route 10 West, Suite 203 Whippany, NJ 07981 908-204-0004 For SmallCapVoice.com Stuart T. Smith 512-267-2430 [email protected]


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 



